Researchers explored the feasibility of integrating pharmacists into the oncology care team for older patients with cancer to determine the impact this intervention would have on medication management and vaccination uptake.
HPV Vaccination and Anti-programmed Cell Death 1 Inhibition Improve Survival in Patients With Invasive HPV-16October 16, 2018
In this study, researchers sought to determine if use of a tumor specific vaccine would improve the efficacy of PD-1 immune checkpoint inhibition in patients with incurable HPV-16 cancer.
Updated vaccine designed to prevent cancers and disease caused by nine HPV types
What information is there about using the newer high-dose flu vaccine in patients with cancer?
Canadian investigators conducted a national observational study in which women and girls living with HIV underwent HPV vaccination.
Reinforcing the immune system with a the PVX-410 vaccine may prevent or slow progression to multiple myeloma.
High-certainty evidence for cervical cancer protection in adolescent girls and young women aged 15 to 26 years.
A nurse-drive protocol tackled the influenza and pneumococcal vaccine uptake rates at an NCI-designated comprehensive cancer center, according to a presentation at 2018 ONS Annual Congress.
In this study, a vaccine was developed using dendritic cells (DCs) derived from each patient's own peripheral blood mononuclear cells.
iPSC vaccine prevented tumor growth in syngeneic murine breast CA, mesothelioma, melanoma models
Which vaccines should be avoided in patients receiving chemotherapy?
In a comparison of vaccinated vs unvaccinated young adults, oral HPV infection prevalence was found to be substantially lower in persons 18 to 33 years who received at least 1 vaccine-dose during the study years.
Axalimogene filolisbac, an intravenous vaccine currently in clinical trials, could prevent often-fatal cervical cancer relapse.
Seasonal influenza vaccination was associated with increased rates of immunologic toxicity in patients with lung cancer receiving PD-1/PD-L1 immunotherapy blockade.
ASCO offers global recommendations for HPV vaccination tailored to structural resource levels of regions.
Self-persuasion is more effective than external persuasion for motivating low-income parents to vaccinate their children against HPV.
The top reasons for not initiating HPV vaccination are necessity, safety, and knowledge, rather than a lack of discussions on sexuality.
A comparison of administering the influenza vaccine concurrently with chemotherapy with that of administration within the cytopenic period during 3-week chemotherapy cycles determined which schedule was the optimal timing for vaccination administration in this group.
A recent study examined the current economic burden attributable to vaccine-preventable diseases among U.S. adults.
Although HPV vaccination is expected to decrease the cancer burden from HPV across all racial and ethnic groups, some disparities are expected to persist and widen if their causes are not addressed, including lack of access to screening, timely diagnoses, and treatment.
Oncologists should raise awareness of HPV-related cancers and role of vaccinations
Teen girls living in high-poverty and in majority Hispanic communities had the highest rates of having received at least 1 dose of the HPV vaccine compared with those in low-poverty communities and in communities of other racial or ethnic compositions.
Many pediatricians and primary care physicians reported communicating about HPV vaccination with parents in ways that likely discourage them from having their children vaccinated.
Physicians failing to recommend it or adequately explain its benefits to parents could be a factor.
A sizable minority of doctors does not strongly endorse HPV vaccination nor deliver timely recommendations.
Immunization protects against sexually transmitted disease and certain cancers, health experts say, but only two U.S. states mandate vaccination.
Reports on outbreaks of measles, pertussis in past year may have shifted opinions on vaccination.
Researchers note that CDC recommends vaccination at age 11 or 12, but only half of girls receiving the vaccination get it at the proper age.
An experimental breast cancer vaccine boosts immune response and appears to slow spread in those with advanced disease.
Vaccine is effective even among older adults who subsequently undergo chemotherapy.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Patients and Caregivers Worry About Cost of Cancer Care
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Seeking an Explanation for the Lack of Research Focused in Pediatric Oncology Therapeutics
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|